Find your next paid study

~$10 – $1,125

Actual pay is set by the research site.

Mary LacyNCT07888179

Recurrent Astrocytoma, IDH-Mutant, Grade 3Recurrent Astrocytoma, IDH-Mutant, Grade 4Recurrent Glioblastoma

A Phase 1 Trial to Evaluate the Safety of IL13Rα2-Targeting Chimeric Antigen Receptor (CAR) T Cells With CRISPR Knockout of TGFβR2 in Patients With Recurrent or Progressive High-Grade Glioma (HGG)

This phase I trial tests the safety, side effects and best dose of TGFβR2KO/IL13Rα2 chimeric antigen receptor (CAR) T-cells given within the skull (intracrania…

City of Hope Medical CenterNCT06815029

~$150 – $3,000

Actual pay is set by the research site.

Ulnar Nerve Transposition

Is Splinting After Ulnar Nerve Transposition Necessary?

The goal of this clinical trial is to learn whether patient recovery after ulnar nerve transposition (UNT) requires a splint. The main questions it aims to ans…

University of ChicagoNCT07880470

Actual pay is set by the research site.

DementiaCancerRenal Disease+1 more

Using Community Health Workers to Support Rural Care Partners of Seriously Ill Older Veterans

The investigators aim to support care partner's well-being and satisfaction with VA care and decrease their work burden by offering extra support from a traine…

VA Office of Research and DevelopmentNCT06963970

~$10 – $675

Actual pay is set by the research site.

Phase 3

An Open-label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of 12 Month Treatment With Migalastat in Pediatric Subjects (Aged 2 to < 12 Years) With Fabry Disease and Amenable GLA Variants

An open-label study to evaluate the safety, pharmacokinetics (PK), pharmacodynamics (PD), and efficacy of migalastat treatment in pediatric subjects 2 to \< 12…

Fabry Disease

Amicus TherapeuticsNCT06904261

~$50 – $2,100

Actual pay is set by the research site.

Trans-auricular Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering From Sickle Cell Disease

The goal of this study is to evaluate the effects of transauricular vagus and trigeminal nerve stimulation on the treatment of pain in children with Sickle Cel…

Sickle Cell Disease

Emory UniversityNCT07090668

Actual pay is set by the research site.

Platinum-resistant Ovarian Cancer

A Phase 1, Open-Label, Dose-Escalation Study Evaluating the Safety and Tolerability of GB-5267, an IL-18 Armored CAR T Cell Product Targeting MUC16, in Patients With Platinum-Resistant Ovarian Cancer

This phase 1 study evaluates the safety, efficacy, and biological activity of GB-5267 in patients with platinum-resistant ovarian cancer.

Roswell Park Cancer InstituteNCT07489287

~$150 – $4,500

Actual pay is set by the research site.

Locally Advanced or Metastatic Malignant Solid Tumors

A Phase 1b/2 Study of ASP2998 as Monotherapy and in Combination With Standard Therapies in Participants With Locally Advanced Unresectable or Metastatic Solid Tumors

Specific proteins found in tumors help the tumors spread and grow. People with solid tumors often have a protein called TROP2 in their tumor. ASP2998 is being …

Astellas Pharma Global Development, Inc.NCT07287995

~$150 – $4,200

Actual pay is set by the research site.

Carrier of PhenylketonuriaHealthy

The Impact of Phenylalanine Elevations on Metabolic, Cognitive, and Neural Functioning in Adults Heterozygous for Phenylketonuria (PKU)

The goal of this clinical trial is to advance our understanding of the cognitive and neurophysiologic sequelae associated with suboptimal phenylalanine (Phe) m…

University of Missouri-ColumbiaNCT07220265

Actual pay is set by the research site.

Feasibility and Adaptation of a Hospice Transitions Checklist for Hospitalized Persons With Dementia

This is an NIH Stage IB single-arm feasibility study will adapt and test the Inpatient Hospice Transitions Checklist (I-HTC), an Epic-embedded intervention sup…

Dementia

New York UniversityNCT07889830

Actual pay is set by the research site.

Advanced or Metastatic Solid TumorsTriple Negative Breast Cancer (TNBC)HR+ Breast Cancer+8 more

A Phase 1 Multicenter, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SHY-ONC6 in Participants With Advanced or Metastatic Solid Tumors

This is a Phase 1, first-in-human (FIH), open-label, multicenter study designed to evaluate the safety, tolerability, PK, and preliminary anti-tumor activity o…

SHY TherapeuticsNCT07705334

~$150 – $4,200

Actual pay is set by the research site.

Ventral HerniaVentral Incisional HerniaPost Operative Pain

The IMPACT Study: A Randomized Controlled Trial of Individualized Management Post Ventral Hernia Repair (VHR) Utilizing Abdominal Core Therapy for Enhanced Recovery and Health Outcomes

Ventral hernia repair is among the most common operations performed in the United States each year, yet the great majority of patients receive no structured re…